Defining goals for molecular remission in Chronic Myeloid Leukemia.
Hematology 2002 Druker 111 35
“I’ve been diagnosed with CML. What’s the best initial treatment for me?”
Secondary Messenger System
1 One Year Post Exclusivity Adverse Event Monitoring as mandated by the Best Pharmaceuticals for Children Act Dr. Solomon Iyasu Medical Team Leader Dr.
